Discover 1,271 paid clinical trials in Surprise, Arizona. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,271
An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal Onset or Tonic-Clonic Seizures
for
Focal Onset Seizure, Primary Generalized Epilepsy
Location: Phoenix AZ, Round Rock TX, Seabrook TX, Chesterfield MO,
Sponsor: Praxis Precision Medicines
Sex: All
Age: 18 - 70+
Code: NCT06908356
Phase2, Recruiting
A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer
for
HER2-positive Gastric Cancer,
Location: Phoenix AZ, La Jolla CA, Upland CA, Duarte CA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06764875
Phase3, Recruiting
AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)
for
Relapsed/Refractory Multiple Myeloma
Location: Phoenix AZ, La Jolla CA, Los Angeles CA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT05850234
Phase1, Phase2, Recruiting
A Platform Study in Non-Small Cell Lung Cancer (NSCLC)
for
Advanced or Metastatic Non-small Cell Lung Cancer
Location: Phoenix AZ, Santa Rosa CA, Tyler TX, Rochester MN,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06996782
Phase1, Phase2, Recruiting
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
Location: Phoenix AZ, Lone Tree CO, Walnut Creek CA, Dallas TX,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07431281
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)
for
Biliary Tract Cancer
Location: Phoenix AZ, Tucson AZ, Orange CA, Duarte CA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07221253
Phase3, Recruiting
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
for
Prostate Cancer
Location: Phoenix AZ, San Diego CA, La Jolla CA, Los Angeles CA,
Sponsor: AstraZeneca
Sex: Male
Age: 18+
Code: NCT06952803
Phase3, Recruiting
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
for
Hepatocellular Carcinoma
Location: Phoenix AZ, Tucson AZ, Los Angeles CA, Amarillo TX,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06921785
Phase3, Recruiting
Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation
for
Delayed Graft Function, DGF, Kidney Transplant
Location: Phoenix AZ, Los Angeles CA, Stanford CA,
Sponsor: Alexion Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT06830798
Phase3, Recruiting
Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC
for
Hepatocellular Carcinoma (HCC)
Location: Phoenix AZ, Tucson AZ, Orange CA, Houston TX, Omaha NE,
Sponsor: RayzeBio, Inc.
Sex: All
Age: 18+
Code: NCT06726161
Phase1, Phase2, Recruiting
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC
for
Non-squamous Non-small Cell Lung Cancer
Location: Phoenix AZ, San Diego CA, Redlands CA, Loma Linda CA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06627647
Phase3, Recruiting
Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease
for
Proteinuric Kidney Disease
Location: Phoenix AZ, Las Vegas NV, Los Angeles CA,
Sponsor: Vertex Pharmaceuticals Incorporated
Sex: All
Age: 10 - 65
Code: NCT05312879
Phase2, Phase3, Recruiting
Safety and Immunogenicity of an Intranasal Vaccine for Respiratory Syncytial Virus in Seronegative Children 6-36 Months
for
Respiratory Syncytial Virus (RSV)
Location: Phoenix AZ, San Antonio TX, Omaha NE, Metairie LA,
Sponsor: Meissa Vaccines, Inc.
Sex: All
Age: 0 - 3
Code: NCT04909021
Phase1, Recruiting
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
for
Non-Small Cell Lung Cancer
Location: Phoenix AZ, Chandler AZ, San Diego CA, Orange CA,
Sponsor: Summit Therapeutics
Sex: All
Age: 18+
Code: NCT06767514
Phase3, Recruiting
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
for
Overweight, Obesity
Location: Phoenix AZ, Scottsdale AZ, Tucson AZ, San Diego CA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07392190
Phase3, Recruiting
A Phase 2/3 Study of Brepocitinib in Adults With Lichen Planopilaris
for
Lichen Planopilaris
Location: Phoenix AZ, Scottsdale AZ, Irvine CA, Murray UT,
Sponsor: Priovant Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07532603
Phase2, Phase3, Recruiting
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
for
Psychosis Associated With Alzheimer's Disease
Location: Phoenix AZ, Scottsdale AZ, Tucson AZ, Las Vegas NV,
Sponsor: MapLight Therapeutics
Sex: All
Age: 55 - 70+
Code: NCT06887192
Phase2, Recruiting
International Multicentric Observational Study to Characterize Subpopulations of Patients With Autism Spectrum Disorder
for
Autism Spectrum Disorder
Location: Phoenix AZ, Sherman Oaks CA, Clinton UT, Columbia MO,
Sponsor: Stalicla SA
Sex: All
Age: 12 - 65
Code: NCT05590715
Recruiting
Microbiota Transfer Therapy for Children and Adults With Both Pitt Hopkins Syndrome and Gastrointestinal Disorders
for
Pitt Hopkins Syndrome
Location: Tempe AZ
Sponsor: Gut-Brain-Axis Therapeutics Inc.
Sex: All
Age: 5 - 55
Code: NCT06321796
Phase2, Recruiting
Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder